Delivery Order SPE2DB22D1202-SPE2DB23FHWN7
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251,420 delivery order by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing over a period of four days from August 4th through the 7th of 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $334.47 firm fixed price delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication, for performance at its Conshohocken, Pennsylvania facility from July 21-24, 2023. The award is issued against the DLA's pharmaceutical prime vendor contract vehicle to support the medical readiness of DOD personnel. No subcontractors...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502.86 delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania. Performance will take place from August 30 to August 31, 2023 under firm fixed pricing. The award was issued against DLA's prime vendor pharmaceutical contracts to support the medical readiness programs...
- Amerisourcebergen Drug Corp has been awarded a $1,002.12 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply 50 MG/0.5 ML auto-injectors of XYOSTED, a medication for testosterone replacement therapy. Performance will occur in Conshohocken, Pennsylvania by October 2023. The Defense Logistics Agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to the Department of Defense. No...
- The Defense Logistics Agency awarded a $6,165.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be in Conshohocken, Pennsylvania over the period of August 1-2, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling this order to supply the injectable testosterone cypionate product in support of DLA programs. No major...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $927 to Amerisourcebergen Drug Corporation for the supply of 50 milligram per 0.5 milliliter doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will occur in Conshohocken, Pennsylvania over a one day period from July 26 to July 27, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the...
- The Defense Logistics Agency awarded a $3,433.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED, a testosterone replacement therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order is likely part of DLA's...
- The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561521698 XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the 0.5mL auto-injectable testosterone cypionate product to a location in Conshohocken, Pennsylvania by July 18, 2023 to support Defense Logistics Agency requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,393.85 from the Defense Logistics Agency (DLA) to supply 50 milligrams per 0.5 milliliter doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with all work to be completed by November 29, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by Amerisourcebergen with...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHWN7Delivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,508.58 delivery order contract by the Defense Logistics Agency to supply XYOSTED, a testosterone replacement therapy medication. Performance will take place in Conshohocken, Pennsylvania over a one day period from July 26-27, 2023. The firm fixed price contract was awarded under the DLA's pharmaceuticals and medical/surgical supply vehicle. No subcontractors or set aside designations were indicated. This supports the DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide.
Generated 12/24/23, 4:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/26/23 |